Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

XTalks

MARCH 18, 2025

Standard treatment strategies include combinations of antibiotics, hormonal therapies and biologic agents most notably adalimumab (Humira), the only FDA-approved biologic for moderate to severe cases while surgery remains an option for advanced disease.

Trials 59

Trials Clinical Trials Clinical Trials Hormones 59

Olympian Clinical Research

MARCH 1, 2024

If you are wondering how to remove age spots, Academic Alliance in Dermatology can help. Genetics, hormonal changes, and certain medications can also play a role in developing age spots. Our team of experienced dermatology providers can help you determine the most suitable treatment plan tailored to your specific needs.

Dermatology 52

Dermatology Production Cosmetics Hormones 52

The Pharma Data

JULY 22, 2021

Immune-mediated adverse reactions can occur at any time during or after treatment with KEYTRUDA, including pneumonitis, colitis, hepatitis, endocrinopathies, nephritis, dermatologic reactions, solid organ transplant rejection, and complications of allogeneic hematopoietic stem cell transplantation.

HR 52

HR Trials Dermatology Hormones 52

The Pharma Data

APRIL 4, 2023

Immune-mediated adverse reactions can occur at any time during or after treatment with KEYTRUDA, including pneumonitis, colitis, hepatitis, endocrinopathies, nephritis, dermatologic reactions, solid organ transplant rejection, and complications of allogeneic hematopoietic stem cell transplantation. Initiate hormone replacement as indicated.

FDA Approval 40

FDA Approval Containment Hormones Dermatology 40